Preventing PIP3 loss through PTEN inhibition reduces left ventricular hypertrophy and preserves cardiac function without affecting myocyte Ca2+ handling or cytoarchitecture, suggesting its effects occur primarily through reduction of fibrosis. The gene discussed is PTEN; the disease is left ventricular hypertrophy.